LysoLipid Research - New LPA Antibody From Echelon Biosciences, Supplier to MoBiTec, Germany

GÖTTINGEN, Germany - May 25, 2018 - PRLog -- Lysophosphatidic Acid (LPA) is a serum-derived phospholipid involved in diverse cellular processes. Recent research indicates LPA may play a significant role in the pathophysiology of cancer and may be used as a biomarker for ovarian cancer. LPA Antibody (504B3) was originally developed and patented at Lpath Therapeutics. Echelon Biosciences has further developed and validated this exciting new antibody for in vitro and cell-based applications.

Lysophosphatidic Acid (LPA) Antibody (504B3)

Catalog No.:  Z-P200

Description:  Purified Anti-Lysophosphatidic Acid (LPA) monoclonal antibody.
Subclass: IgGk
Source: Mouse
Applications: ELISA, Immunohistochemistry, Immunocytochemistry

References:

1) J. Cheng, S. Sahani, T.J. Hausrat, et al. (2016) "Precise Somatotopic Thalamocortical Axon Guidance Depends on LPA-Mediated PRG-2/Radixin Signaling" Neuron, 92(1); 126-142. doi: doi:10.1016/j.neuron.2016.08.035

2) M. Balood, H. Zahednasab, et al. (2014) "Elevated serum levels of lysophosphatidic acid in patients with multiple sclerosis" Hum. Immunol. 75(5); 411-413, doi: 10.1016/j.humimm.2014.02.021

3) Y. Goldshmit, R. Matteo, et al. (2012) "Blockage of lysophosphatidic acid signaling improves spinal cord injury outcomes." Am. J. Pathol. , 181(3): 978-992, doi: 10.1016/j.ajpath.2012.06.007

MoBiTec offers products manufactured by Echelon Biosciences, USA, to its customers throughtout Europe.

For more information or for bulk pricing options contact info@mobitec.com.

Echelon Biosciences Incorporated (EBI) was incorporated under the laws of the state of Utah as Echelon Research Laboratories, Inc. on October 3, 1997. Initially, EBI was formed from a project under the Center for Cell Signaling, a State of Utah Center of Excellence, with the aim to further the science of lipid cell signaling and critical metabolic enzymes, which provide new and viable targets for the development of potential drugs and diagnostics for cancer, diabetes, inflammation, infections, and cardiovascular disease.

MoBiTec GmbH (Goettingen, Germany) is a privately held company (founded in 1987) that offers research tools for molecular and cell biology. Products include DNA vectors for cloning and expression, cell transfection reagents and cell culture tools, immobilized and soluble enzymes, products for genomics and proteomics research, numerous antibodies and recombinant proteins, superior fluorescence reagents and kits, affinity chromatography products, as well as general laboratory equipment.

In parallel to its own product lines, MoBiTec distributes products from international companies in Germany. MoBiTec products are distributed worldwide, in Germany from their home office, in other countries by distributors.